Cancer Screening in Older Patients

Area of Science:

• Geriatric Medicine
• Oncology
• Preventive Medicine

Background:

• Cancer is a leading cause of death in older adults (65+).
• Limited clinical trial data exists on cancer screening effectiveness and harms in this demographic.
• The older population is heterogeneous, necessitating personalized screening strategies.

Purpose of the Study:

• To review current evidence on cancer screening in individuals aged 65 and older.
• To emphasize the need for individualized cancer screening decisions in geriatric populations.
• To provide guidance on when to initiate or discontinue specific cancer screenings.

Main Methods:

• Literature review of clinical trial data and expert recommendations.
• Analysis of survival benefits and harms associated with common cancer screenings.
• Discussion of factors influencing screening decisions in older adults.

Main Results:

• Screening for breast and colorectal cancers may not benefit those with <10 years life expectancy.
• Prostate cancer screening is generally not recommended after age 69.
• Cervical cancer screening can cease at 65 with a history of negative results.

Conclusions:

• Cancer screening decisions in older adults must be individualized, not age-based.
• Estimating life expectancy is crucial for determining screening appropriateness.
• Balancing potential benefits, harms, and patient values is essential for informed screening choices.